Display Settings:

Format

Send to:

Choose Destination
    Am J Psychiatry. 1990 Apr;147(4):492-4.

    Trial of fluoxetine added to neuroleptics for treatment-resistant schizophrenic patients.

    Source

    Erich Lindemann Mental Health Center, Massachusetts General Hospital, Boston.

    Abstract

    Mean ratings of positive and negative symptoms and depression significantly improved in nine treatment-resistant schizophrenic patients who completed a 6-week open trial of fluoxetine added to their neuroleptics. The authors identify differences between responders and nonresponders and recommend controlled trials.

    PMID:
    1969245
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Silverchair Information Systems

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk